GlassScriptPhysician profile
Nakia Lashawn Brooks
NPI 1013187301
$25,184.12
in general payments reported to CMS, 2019-2025
11 companies · $14K in 2025
The $14K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.95 · 2022: $67.13 · 2023: $6,730 · 2024: $4,368 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,699 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,125 · Consulting Fee: $6,250 · Food and Beverage: $2,094 · Honoraria: $1,750 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,698.99 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,125.00 |
| Consulting Fee | $6,250.00 |
| Food and Beverage | $2,094.05 |
| Honoraria | $1,750.00 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $23,884.06 | 2023-2025 | Cabometyx |
| Astrazeneca Pharmaceuticals LP | $523.71 | 2023-2025 | Imfinzi |
| Janssen Biotech, INC. | $165.75 | 2022-2024 | Erleada |
| Incyte Corporation | $126.04 | 2023 | Pemazyre |
| Ipsen Biopharmaceuticals, INC | $106.92 | 2024 | Onivyde |
| Sanofi-Aventis U.S. LLC | $99.95 | 2021 | |
| Abbvie INC. | $83.95 | 2023-2024 | |
| Daiichi Sankyo INC. | $68.62 | 2024-2025 | Enhertu, Datroway |
| Tersera Therapeutics LLC | $62.50 | 2025 | Xermelo |
| Beone Medicines USA, INC. | $43.39 | 2025 | Tevimbra |
| Seagen INC. | $19.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nakia Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.